278 related articles for article (PubMed ID: 19141125)
1. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.
Wang Z; Shi BY; Qian YY; Cai M; Wang Q
Clin Exp Immunol; 2009 Mar; 155(3):496-503. PubMed ID: 19141125
[TBL] [Abstract][Full Text] [Related]
2. CD25 appears non essential for human peripheral T(reg) maintenance in vivo.
de Goër de Herve MG; Gonzales E; Hendel-Chavez H; Décline JL; Mourier O; Abbed K; Jacquemin E; Taoufik Y
PLoS One; 2010 Jul; 5(7):e11784. PubMed ID: 20689592
[TBL] [Abstract][Full Text] [Related]
3. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
4. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.
Vondran FW; Timrott K; Tross J; Kollrich S; Schwarz A; Lehner F; Klempnauer J; Becker T; Schwinzer R
Transpl Int; 2010 May; 23(5):514-23. PubMed ID: 19951265
[TBL] [Abstract][Full Text] [Related]
5. Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA.
Engela AU; Hoogduijn MJ; Boer K; Litjens NH; Betjes MG; Weimar W; Baan CC
Clin Exp Immunol; 2013 Aug; 173(2):343-54. PubMed ID: 23607314
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
[TBL] [Abstract][Full Text] [Related]
7. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
[TBL] [Abstract][Full Text] [Related]
8. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.
Bloom DD; Chang Z; Fechner JH; Dar W; Polster SP; Pascual J; Turka LA; Knechtle SJ
Am J Transplant; 2008 Apr; 8(4):793-802. PubMed ID: 18261176
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the IL-15 pathway in anti-CD25 mAb treated renal allograft recipients.
Baan CC; van Riemsdijk-Overbeeke IC; Boelaars-van Haperen MJ; IJzermans JM; Weimar W
Transpl Immunol; 2002 Jun; 10(1):81-7. PubMed ID: 12182469
[TBL] [Abstract][Full Text] [Related]
10. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.
Okita R; Yamaguchi Y; Ohara M; Hironaka K; Okawaki M; Nagamine I; Ikeda T; Emi A; Hihara J; Okada M
Int J Oncol; 2009 Feb; 34(2):563-72. PubMed ID: 19148493
[TBL] [Abstract][Full Text] [Related]
11. [Regulatory T cells in kidney transplant recipients].
Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.
Hoerning A; Köhler S; Jun C; Lu J; Fu J; Tebbe B; Dolff S; Feldkamp T; Kribben A; Hoyer PF; Witzke O
Clin Exp Immunol; 2012 May; 168(2):251-9. PubMed ID: 22471287
[TBL] [Abstract][Full Text] [Related]
13. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
Vignali D; Gürth CM; Pellegrini S; Sordi V; Sizzano F; Piemonti L; Monti P
Transplantation; 2016 Sep; 100(9):1853-61. PubMed ID: 27306531
[TBL] [Abstract][Full Text] [Related]
14. The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.
Kamikozuru K; Fukunaga K; Hirota S; Hida N; Ohda Y; Yoshida K; Yokoyama Y; Tozawa K; Kawa K; Iimuro M; Nagase K; Saniabadi AR; Nakamura S; Miwa H; Matsumoto T
Clin Exp Immunol; 2009 May; 156(2):320-7. PubMed ID: 19292766
[TBL] [Abstract][Full Text] [Related]
15. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
Bayer AL; Yu A; Malek TR
J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
[TBL] [Abstract][Full Text] [Related]
16. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
Bluestone JA; Liu W; Yabu JM; Laszik ZG; Putnam A; Belingheri M; Gross DM; Townsend RM; Vincenti F
Am J Transplant; 2008 Oct; 8(10):2086-96. PubMed ID: 18828769
[TBL] [Abstract][Full Text] [Related]
17. In vitro selective depletion of CD4(+)CD25(+) regulatory T-cells from PBMC using anti-tac-SAP.
Akbari A; Rezaei A
J Immunotoxicol; 2012; 9(4):368-73. PubMed ID: 22506556
[TBL] [Abstract][Full Text] [Related]
18. Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion.
Okawaki M; Yamaguchi Y; Okita R; Ohara M; Okada M
Hiroshima J Med Sci; 2008 Mar; 57(1):37-46. PubMed ID: 18578365
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients.
Vafadari R; Quaedackers ME; Kho MM; Mol WM; Chan G; Weimar W; Baan CC
Transplantation; 2012 Sep; 94(5):465-72. PubMed ID: 22960764
[TBL] [Abstract][Full Text] [Related]
20. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]